Results of a Phase I-II Study of Fenretinide and Rituximab for Patients with B-Cell Lymphomas

被引：0

作者：

Cowan, Andrew J. ^{[1
]}

Stevenson, Philip ^{[2
]}

Gooley, Ted A. ^{[2
]}

Frayo, Shani L. ^{[2
]}

Oliveira, George R. ^{[3
]}

Smith, Stephen D. ^{[1
,4
]}

Green, Damian J. ^{[1
,2
]}

Roden, Jennifer E. ^{[5
]}

Pagel, John M. ^{[6
]}

Wood, Brent L. ^{[4
,7
]}

Press, Oliver W. ^{[1
,4
]}

Gopal, Ajay K. ^{[1
,8
]}

机构：

[1] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA

[2] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA

[3] Harvard Univ, Sch Med, Dept Radiol, MGH Hosp, Boston, MA 02115 USA

[4] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA

[5] Univ Washington, Dept Med, Seattle, WA USA

[6] Swedish Med Ctr, Seattle, WA USA

[7] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA

[8] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B-cell nonfollicular lymphomas [J].

Ferrario, Andrea ;

Pulsoni, Alessandro ;

Olivero, Barbara ;

Rossi, Giuseppe ;

Vitolo, Umberto ;

Tedeschi, Alessandra ;

Merli, Francesco ;

Rigacci, Luigi ;

Stelitano, Caterina ;

Goldaniga, Maria ;

Mannina, Donato ;

Musto, Pellegrino ;

Rossi, Francesca ;

Gamba, Enrica ;

Baldini, Luca .

CANCER, 2012, 118 (16) :3954-3961

[42] Risk of HBV reactivation in patients with B-cell lymphomas receiving obinutuzumab or rituximab immunochemotherapy [J].

Kusumoto, Shigeru ;

Arcaini, Luca ;

Hong, Xiaonan ;

Jin, Jie ;

Kim, Won Seog ;

Kwong, Yok Lam ;

Peters, Marion G. ;

Tanaka, Yasuhito ;

Zelenetz, Andrew D. ;

Kuriki, Hiroshi ;

Fingerle-Rowson, Gunter ;

Nielsen, Tina ;

Ueda, Eisuke ;

Piper-Lepoutre, Hanna ;

Sellam, Gila ;

Tobinai, Kensei .

BLOOD, 2019, 133 (02) :137-146

[43] Phase II study of rituximab after priming with IFN in patients with relapsed LG/F B-cell lymphoma. [J].

Sacchi, S ;

Federico, M ;

Vitolo, U ;

Boccomini, C ;

Vallisa, G ;

Baldini, L ;

Petrini, M ;

Rupoli, S ;

Di Raimondo, F ;

Merli, F ;

Liso, V ;

Tabilio, A ;

Saglio, G ;

Di Renzo, N ;

Gobbi, P ;

Pitini, G ;

Quarta, G ;

Brugiatelli, M ;

Vinci, G ;

Dastoli, G .

BLOOD, 1999, 94 (10) :91A-91A

[44] Multicenter Phase II Study of Bendamustine Plus Rituximab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma [J].

Ohmachi, Ken ;

Niitsu, Nozomi ;

Uchida, Toshiki ;

Kim, Seok Jin ;

Ando, Kiyoshi ;

Takahashi, Naoki ;

Takahashi, Naoto ;

Uike, Naokuni ;

Eom, Hyeon Seok ;

Chae, Yee Soo ;

Terauchi, Takashi ;

Tateishi, Ukihide ;

Tatsumi, Mitsuaki ;

Kim, Won Seog ;

Tobinai, Kensei ;

Suh, Cheolwon ;

Ogura, Michinori .

JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) :2103-+

[45] A MULTICENTER PHASE II STUDY OF BENDAMUSTINE WITH RITUXIMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) [J].

Kim, W. S. ;

Ando, K. ;

Niitsu, N. ;

Ogura, M. ;

Takahashi, N. ;

Uike, N. ;

Eom, H. Seok ;

Chae, Y. S. ;

Tobinai, K. ;

Terauchi, T. ;

Tateishi, U. ;

Tatsumi, M. ;

Suh, C. .

ANNALS OF ONCOLOGY, 2012, 23 :94-94

[46] Clofarabine is active in peripheral T-cell lymphomas: Results of the phase I portion of a phase I/II study [J].

Horwitz, S. ;

Mulford, D. ;

Paul, H. ;

Weissbrot, H. ;

Zelenetz, A. D. .

ANNALS OF ONCOLOGY, 2008, 19 :157-157

[47] Radioimmunotherapy (RIT) with 177 Lutetium-DOTA-Rituximab (177LU-D-R): A Phase I/II - Study in 30 Patients with Relapsing Follicular, Mantle Cell and Other Indolent B-Cell Lymphomas [J].

Lohri, Andreas ;

Forrer, Flavio ;

Campana, Benedetta ;

Mamot, Christoph ;

Winterhalder, Ralph ;

Herrmann, Richard ;

Maecke, Helmuth R. ;

Mueller-Brand, Jan .

BLOOD, 2008, 112 (11) :1050-1050

[48] Results of a Phase I/II Study of Bendamustine in Combination with Ofatumumab, Carboplatin and Etoposide (BOCE) for Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas [J].

Pan, Jonathan ;

Ghimire, Sushil ;

Zhan, Tingting ;

Alpdogan, Onder ;

Chapman, Andrew E. ;

Carabasi, Matthew ;

Martinez-Outschoorn, Ubaldo ;

Rose, Lewis J. ;

Ramirez, Michael ;

Wagner, John L. ;

Pro, Barbara ;

Weiss, Mark A. ;

Flomenberg, Neal ;

Porcu, Pierluigi ;

Filicko-O'Hara, Joanne ;

Gaballa, Sameh .

BLOOD, 2019, 134

[49] Prognostic significance of the histopathologic recognition of low- and high-grade components in stage I-II B-Cell gastric lymphomas [J].

Ferreri, AJM ;

Freschi, M ;

Dell'Oro, S ;

Viale, E ;

Villa, E ;

Ponzoni, M .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (01) :95-102

[50] A phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL [J].

Jain, Nitin ;

Balakrishnan, Kumudha ;

Ferrajoli, Alessandra ;

O'Brien, Susan M. ;

Burger, Jan A. ;

Kadia, Tapan M. ;

Cortes, Jorge E. ;

Ayres, Mary L. ;

Tambaro, Francesco Paolo ;

Keating, Michael J. ;

Gandhi, Varsha ;

Wierda, William G. .

ONCOTARGET, 2017, 8 (13) :22104-22112

← 1 2 3 4 5 →